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ABSTRACT
Objectives: The increase in HIV transmissibility in non-ulcerative sexually transmitted 
infection is already well-established. It is estimated that symptomatic carriers of 
N. gonorrhoeae and C. trachomatis have a relative risk of 4.8-fold and 3.6-fold, respectively, 
for the sexual acquisition of HIV. This type of evaluation for asymptomatic urethritis is 
necessary to reinforce strategies to combat HIV transmission. This study aims to assess 
the prevalence of patients with asymptomatic urethritis among men diagnosed with HIV-1 
and determine the risk factors associated with this infection. Methods: We enrolled a total 
of 115 male patients aged 18 years or older who have been diagnosed with HIV infection 
and have no symptoms of urethritis or other sexually transmitted infections and who have 
been evaluated between May and August 2015 in a follow-up visit at the Immunology 
Outpatient Clinic of a Brazilian University Hospital. Results: Four asymptomatic patients 
were positive for C. trachomatis and were considered asymptomatic carriers of urethritis. 
Prevalence was 3.47%. Patients who were positive for C. trachomatis urethritis had a lower 
mean age (p = 0.015). Conclusion: The presence of asymptomatic sexually transmitted 
infection is a challenge in clinical practice. We recommend that, in outpatient practice, the 
habit of inquiring on previous sexual behavior to obtain more information about risks and 
associations with asymptomatic sexually transmitted infection, a routine physical examination 
and complementary tests to detect STI pathogens should be performed to discard these 
conditions. The development of rapid tests for this purpose should also be encouraged.
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INTRODUCTION
Chlamydia trachomatis is the etiological agent of the most prevalent sexually 
transmitted infection (STI) worldwide1. Considering that a large percentage of C. 
trachomatis infections is asymptomatic, many countries have established public 
health strategies for infection screening and control2,3. In a study that aimed to 
ascertain the prevalence of asymptomatic urethritis by C. trachomatis in military 
men aged 17 to 24 years in Brazil, a prevalence of 5% was found among 523 
individuals using urine samples tested by polymerase chain reaction (PCR)3. Other 
similar studies in the United States showed a prevalence of 1.5%, 3.7% and 5.7%4-6.
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Regarding the prevalence of asymptomatic urethritis by 
Neisseria gonorrhoeae among men, one study showed a 
prevalence of 0.6% of N. gonorrhoeae urethritis and 5.7% 
of C. trachomatis. In total, 86% of C. trachomatis carriers 
and 60% of N. gonorrhoeae carriers were asymptomatic. 
This study demonstrated that, in addition to the finding that 
C. trachomatis is a more prevalent cause of urethritis, it is 
more frequently asymptomatic than N. gonorrhoeae7. Few 
studies have determined the risk profile for asymptomatic 
carriers of C. trachomatis. The main risk factors established 
in the literature are: age under 25 years, irregular use or 
negligence in condom use, new sexual partners for less 
than 60 days and STI history, without a direct reference 
to AIDS8,9.
The increase in HIV transmissibility in non-ulcerative 
STI is already well-established. This type of evaluation 
of asymptomatic urethritis is necessary to reinforce 
strategies to combat HIV transmission. It is estimated that 
symptomatic carriers of N. gonorrhoeae and C. trachomatis 
have a relative risk of 4.8 and 3.6, respectively, for the sexual 
acquisition of HIV10. A review of studies related to STI 
and HIV transmissibility concluded that the relative risk 
for transmission was between two and five and that early 
and strict STI control would undoubtedly have an impact 
on the virus transmissibility11.
In a study that aimed to measure the seminal viral 
load among HIV-infected individuals with symptomatic 
urethritis, HIV viral load in the semen of these individuals 
was eight times higher than in patients without symptomatic 
urethritis. Gonorrhea was the urethritis etiology with 
the greater strength of association, and, after treatment, 
there was a significant drop of HIV viral load in the 
semen12.
Considering that the history of STI is a risk factor for 
asymptomatic urethritis, we could expect that HIV-positive 
patients would have a higher prevalence of the disease. 
Theoretically, the immunodeficiency status associated with 
HIV infection may cause the subject to be less symptomatic 
because of a lower local immune response, and individuals 
with a lower CD4+ T-lymphocyte count could be more 
prone to asymptomatic urethritis. Among those with a 
CD4+ T-lymphocyte count that is lower than 200 cells/mm3, 
trimethoprim-sulfamethoxazole (TMS) prophylaxis 
against pneumocystosis and neurotoxoplasmosis could 
treat possible asymptomatic urethritis, and, among those 
with a CD4+ T-lymphocyte count lower than 50 cells/mm³, 
azithromycin prophylaxis against Mycobacterium avium 
complex could treat possible asymptomatic urethritis, 
consequently reducing the prevalence in this group12.
This study aims to assess the prevalence of patients 
with asymptomatic urethritis caused by C. trachomatis and 
N. gonorrhoeae among men diagnosed with HIV-1 and 
determine the risk factors associated with this infection. 
We have also studied associations with sexual behavior and 
condom use in this population.
MATERIALS AND METHODS
Patient Recruitment
In this analytical cross-sectional study, a total of 115 
male patients were enrolled, including only those who 
were diagnosed with HIV infection and no symptoms of 
urethritis or other STI, aged 18 years or older, who were 
evaluated between May and August of 2015, among a 
total of314 patients in a follow-up visit at the Immunology 
Outpatient Clinic of the Gaffrée and Guinle University 
Hospital. The Hospital was chosen because it is one of 
the biggest centers in number of patients and one of the 
main references in the treatment of HIV infection in the 
country.  Exclusion criteria were: refusal to participate 
in the study (13 patients – 4.1%), younger than 18 years 
(99 patients – 31.5%), those who were unable to perform 
the exams, patients presenting with urinary symptoms (27 
patients – 8.5%), or who did not attend the scheduling 
phases of collection or treatment (60 patients – 19.1%). 
All patients signed informed consent forms and the study 
followed all the guidelines for experimental investigation 
and ethical standards with human subjects required by 
the institution and Resolution 466/2012 of the Brazilian 
National Health Council (CNS) on Ethics in Research with 
human beings Treatment with azithromycin 1 g orally in 
a single dose was offered free of charge for all diagnosed 
patient and partner(s).
Specimen Collection and Laboratory Testing
The clinical and epidemiological study consisted 
of data collection from medical records and interviews 
conducted by the researcher responsible for data collection, 
regarding age, date of birth, place of residence, date of first 
attendance, date of first anti-HIV-1 positive exam, date 
of onset of antiretroviral (ART) regimen, ART treatment 
(yes or no), current ART regimen, outpatient follow-up (in 
years), marital status, schooling (in years), circumcision 
(yes or no), virus exposure category (sexual, parenteral, 
vertical), sexual habits (men and/or women), previous use 
of antibiotics in the past year, use of antibiotic prophylaxis, 
frequency of condom use, alcoholism defined as the regular 
use of alcoholic beverages in quantities sufficient to cause 
significant social, interpersonal, family and/or organic 
problems and use of illicit drugs.
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Demographic and Clinical Data Collection
Urine was collected and tested by real-time PCR for the 
detection of C. trachomatis and N. gonorrhoeae (Abbott 
RealTime CT/NG test®). Simultaneous blood collection was 
performed to obtain HIV viral load values (detection level 
of 40 copies/ml) and CD4+ T-lymphocyte counts.
Data Analysis and Statistical Calculations
The descriptive analysis of the data was performed 
by calculating the mean and standard deviation for 
continuous variables and the frequency analysis for 
categorical variables. The associations between categorical 
and continuous variables were assessed by analysis of 
variance followed by comparison of means by the t-test, 
of categorical variables by the chi-square test and of 
continuous variables by linear correlation analyzing the β 
(angular coefficient) and R2 (coefficient of determination). 
The non-parametric Wilcoxon-Mann-Whitney test was used 
for analysis between two independent populations with 
categorical variable distributions. We used a multivariate 
logistic regression using as covariates those which were 
statistically significant, binaries and categorical, in order 
to identify variables independently associated with the 
diagnosis of asymptomatic urethritis. The level of statistical 
significance was set to 5%. The programs SPSS® 17.0 and 
Epi Info 7® were used for analyses. 
Ethical Approval
This study was approved by the Ethical Committee 
from UNIRIO, Rio de Janeiro, Brazil.  Process 
Nº 02366912.1.0000.5248.
RESULTS
Patient Recruitment and Demographics
We evaluated 115 male patients who met the inclusion 
criteria of the study. After the information collection 
with the help of medical records, the interview and the 
laboratory tests, the profile of the studied population could 
be determined (Tables 1 and 2). The mean age of the studied 
participants was 44.57 years, the majority (74.8%) was 
unmarried and 37.4% had completed high school.
HIV treatment
Regarding the AIDS treatment data, the mean time of 
diagnosis was 10.45 years, with an average of 4.64 years of 
ART, of which 91.2% of the patients were using ART, 17.5% 
were on prophylaxis with TMS with or without macrolide, 
mean CD4+ T-lymphocyte count of 499.61 cells/mm3, and 
70.5% of patients had undetectable plasma HIV viral load. 
Most of them (61.7%) denied the use of any antibiotic in 
the past year.
Behavior and Condom Use 
Regarding lifestyle habits, 96.5% of the patients reported 
sexual intercourse as the form of acquisition of the HIV 
infection, with 38.3% of patients reporting sexual practices 
only with women, 30.4% reporting sexual practices only 
with men and 31.3% reporting sexual practices with men 
and women. The majority (78.3%) had already had insertive 
anal sex, and the majority (56.5%) reported using condoms 
in more than 50% of intercourses. Of those studied, 19.1% 
were circumcised, 9.7% reported having problems with 
alcoholism and 27% used some type of illicit drug.
Prevalence of Urethritis
Results obtained from PCR of urine samples revealed 
that, in the sample of 115 patients, four were asymptomatic 
carriers of urethritis, all of them were positive only for C. 
trachomatis. Prevalence of asymptomatic urethritis was 
3.47%. The comparison of the descriptive data between the 
group with asymptomatic urethritis and the group without 
asymptomatic urethritis is shown in Tables 1 and 2.
Data analysis
After statistical analysis, we observed that age is 
associated with the ART use time (β = positive, R2 = 0.082, 
p <0.01) and that the mean age of patients who do not use 
condoms is higher than those who use condoms in more than 
or equal to 50% of the intercourses (p = 0.03). Likewise, the 
mean age in patients who use condoms in less than 50% of 
intercourses is higher than that of patients who use condoms 
in more than or equal to 50% of intercourses (p = 0.04).
Being a single man is associated with sexual intercourse 
with other men or with men and women (OR = 11.9 
(4.25-33) p <0.01) and condom use in more than 50% of 
intercourses (OR = 3.4 (1.39-8.15) p <0.01). The time since 
diagnosis was associated with the ART use time (p = 0.01) 
and the ART use at all (p = 0.021). The ART use time is 
associated with the CD4+ T-lymphocyte count (β = positive, 
R2 = 0.073, p <0.01), and those with undetectable HIV 
plasma viral loads have a longer mean ART time (p < 0.01). 
Those who do not use ART are associated with a higher 
mean CD4+ T-lymphocyte count (p = 0.015), while those 
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who use ART are associated with undetectable plasma HIV 
viral load (OR = 0.1 (0.01-0.4) p <0.01).
Uncircumcised men are associated with the highest 
plasma HIV viral loads among patients with detectable 
HIV load when compared to circumcised men (p <0.01). 
Patients requiring prophylaxis (CD4+ T-lymphocyte count 
< 200 cell/mm3) are associated with detectable HIV viral 
load (OR = 4.7 (1.62-13.6) p <0.01). There was only a 
tendency of association (p = 0.06) between the use of 
prophylaxis with the mean CD4+ T-lymphocyte count.
When we evaluated the category of exposure to HIV, 
we concluded that parenteral exposure is associated with 
Table 1 - Descriptive analysis and associations between the group with and without urethritis including treatment variables (N = 115)
Variables
Frequencies or means ± SD
OR 
95%CI p-valueTotal (N = 115)




Age  (years) 44.57 ± 10.9 45.04 ± 10.6 31.5 ± 15.15 - 0.015*
Marital status
Single 86/115 (74.8%) 83/111 (74.8%) 3/4 (75%) -
Married 23/115 (20%) 22/111 (19.8%) 1/4 (25%)
Divorced 4/115 (3.5%) 4/111 (3.7%) 0/4 (0%)
Widower 2/115 (1.7%) 2/111 (1.8%) 0/4 (0%) 0.94
Schooling
< 6 yrs 14/115 (12.2%) 14/111 (12.6%) 0/4 (0%)
6-10 yrs 18/115 (15.6%) 16/111 (14.6%) 2/4 (50%)
10-13 yrs 54/115 (47%) 53/111 (47.6%) 1/4 (25%)
Incompl. graduation 13/115 (11.3%) 13/111 (11.7%) 0/4 (0%)
Compl. graduation 16/115 (13.9%) 15/111 (13.5%) 1/4 (25%) 0.77
Time diagnosis  (yrs) 10.45 ± 7.42 10.67 ± 7.45 4.5 ± 2.64 - 0.13
Time ART  (yrs) 4.64 ± 4.13 4.7 ± 4.17 2.67 ± 1.52 - 0.4
ARV
No 10/115 (8.7%) 9/111 (8.1%) 1/4 (25%) 0.26
Yes 105/115 (91.3%) 102/111 (91.9%) 3/4 (75%)  (0.1-2.8) 0.3
Prophylaxis 
No 94/115 (82.5%) 90/111 (82%) 4/4 (100%)
Yes 21/115 (17.5%) 21/111 (18%) 0/4 (0%) Undefined 0.44
Currently Antibiotic 
prophylaxis
none 96/115 (83.3%) 92/111 (82.8%) 4/4 (100%) -
TMS 6/115 (5.3%) 6/111 (5.5%) 0/4 (0%)
Macrolide+TMS 13/115 (11.4%) 13/111 (11.7%) 0/4 (0%) 0.36
Antibiotic last year
No 71/115 (61.7%) 70/111 (63%) 1/4 (25%) 5.1
Yes 44/115 (38.3%) 41/111 (37%) 3/4 (75%)  (0.5-50.0) 0.15
Antibiotic type
none 71/115 (61.7%) 70/111 (63%) 1/4 (25%) -
macrolide 4/115 (3.4%) 4/111 (3.6%) 0/4 (0%)
TMS 7/115 (6.1%) 6/111 (5.5%) 1/4 (25%)
penicillin 18/115 (15.7%) 16/111 (14.4%) 2/4 (50%)
cephalosporins 5/115 (4.4%) 5/111 (4.5%) 0/4 (0%)
quinolone 1/115 (0.8%) 1/111 (0.9%) 0/4 (0%)
RIPE 5/115 (4.4%) 5/111 (4.5%) 0/4 (0%)
aminoglicoside 1/115 (0.8%) 1/111 (0.9%) 0/4 (0%)
fluconazol 1/115 (0.8%) 1/111 (0.9%) 0/4 (0%)
multiple 2/115 (1.9%) 2/111 (1.8%) 0/4 (0%) 0.24
Asymptomatic 
urethritis 3.47% 0% 100%  (CT) -
OR – odds ratio, 95%CI - confidence interval 95%, SD – standard deviation, RIPE – rifampicin/isoniazide/pirazinamide/ethambutol, 
Antibiotic prophylaxis correspond to those individuals who were currently using antibiotics with CD4 count bellow 200 (TMS) or 
50 cels/mm³ (Macrolide+TMS). *(p<0,05).
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alcoholism (OR = 12.8 (1.59-103) p <0.01). Among patients 
with detectable HIV viral load, those who are illicit drug 
users are associated with the lowest mean plasma HIV 
viral loads (p = 0.02). Of the evaluated patients, the CD4+ 
T-lymphocyte count is associated with HIV viral load 
among patients with detectable HIV load (β = negative, 
R2 = 0.2, p <0.01). 
Patients positive for C. trachomatis urethritis had a lower 
mean age (p = 0.015). An overview of the associations found 
in the described sample is included in Tables 3, 4 and 5.
DISCUSSION
The study shows that a portion of the male patients 
living with HIV and treated in a large reference center 
for AIDS present with asymptomatic urethritis. We report 
a prevalence of 3.47% of asymptomatic urethritis in the 
studied sample, all cases caused by C. trachomatis. These 
data can be compared with studies in the general population 
without HIV infection, which report a prevalence of 
asymptomatic urethritis of 5% in military men in Brazil 
Table 2 - Descriptive analysis and associations between the group with and without urethritis including behavior variables (N = 115)
Variables
Frequencies or means ± SD
OR 






Only men 35/115 (30.4%) 33/111 (29.7%) 2/4 (50%) -
Only women 44/115 (38.3%) 42/111 (37.9%) 2/4 (50%)
men and women 36/115 (31.3%) 36/111 (32.4%) 0/4 (0%) 0.18
Insertive anal sex
No 25/115 (21.7%) 25/111 (22.5%) 0/4 (0%)
Yes 90/115 (78.3%) 86/111 (77.5%) 4/4 (100%) Undefined 0.36
Condom
never 10/115 (8.7%) 10/111 (9%) 0/4 (0%) -
<50% 40/115 (34.8%) 39/111 (35.2%) 1/4 (25%)
>50% 65/115 (56.5%) 62/111 (55.9%) 3/4 (75%) 0.41
Circuncision
No 93/115 (80.9%) 89/111 (80.2%) 4/4 (100%)
Yes 22/115 (19.1%) 22/111 (19.8%) 0/4 (0%) Undefined 0.42
Exposure to HIV
Sexual 111/115 (96.5%) 107/111 (96.4%) 4/4 (100%) -
Parenteral 4/115 (3.5%) 4/111 (3.6%) 0/4 (0%)
Vertical 0/115 (0%) 0/111 (0%) 0/4 (0%) 0.7
Alcoholism
No 105/115 (91.3%) 101/111 (91%) 4/4 (100%)
Yes 10/115 (9.7%) 10/111 (9%) 0/4 (0%) Undefined 0.69
Illicit drug use
No 84/115 (73%) 81/111 (73%) 3/4 (75%) 0.9
Yes 31/115 (27%) 30/111 (27%) 1/4 (25%)  (0.1-9.0) 0.7
Drug type
none 83/115 (73%) 80/111 (72%) 3/4 (75%) -
marijuana 7/115 (6.1%) 7/111 (6.6%) 0/4 (0%)
marijuana+cocaine 12/115 (10.4%) 11/111 (10%) 1/4 (25%)
cocaine 7/115 (6.1%) 7/111 (6.6%) 0/4 (0%)
hashish 1/115 (0.9%) 1/111 (0.9%) 0/4 (0%)
>3 drugs 5 (3.5%) 5/111 (4.5%) 0/4 (0%)
outras 0/115 (0%) 0/111 (0%) 0/4 (0%) 0.89
CD4+  (cells/mm³) 499 ± 311 494 ± 311 640 ± 318 - 0.35
Viral load
undetectable 81/115 (70.5%) 79/111 (71.2%) 2/4 (50%)
detectable 34/115 (29.5%) 32/111 (28.8%) 2/4 (50%) 0.33
Viral load  (copies/ml) 100719 ± 213372 106584 ± 219028 9814 ± 9318 0.54
Asymptomatic 
urethritis 3.47% 0% 100%  (CT) -
OR – odds ratio, 95%CI - confidence interval 95%, SD – standard deviation. *(p<0,05).
Silva et al.
Rev Inst Med Trop São Paulo. 2018;60:e11Page 6 of 8
and other similar studies in the United States that presented 
prevalence of 1.5%, 3.7% and 5.7%4-7.
Studies on asymptomatic urethritis specifically in the 
male population living with HIV are scarce, as far as we 
know there are only three. One from the University of 
Birmingham published in 1999 showed a prevalence of 
8% of asymptomatic urethritis; the second study from 
Johannesburg, published in 2012, presented a prevalence 
of asymptomatic urethritis due to C. trachomatis of 2% 
and asymptomatic urethritis due to N. gonorrhoeae of 
4%. The third, from New Orleans published in 2003, 
showed a prevalence of asymptomatic urethritis due to 
C. trachomatis of 2.1% and asymptomatic urethritis due 
to N. gonorrhoeae of 1.7%. A broader assessment of the 
Table 5 - Statistically significant associations between categorical variables (N = 115)
Variable Result
single Sex with men OR = 11.9 (95%CI: 4.25-33). p<0.01
single Condom use ≥ 50% OR = 3.4 (95%CI: 1.39-8.15). p<0.01
ARV use Detectable viral load OR = 0.1 (95%CI: 0.01-0.4). p<0.01
Prophylaxis for opportunistic infections Detectable viral load OR = 4.7 (95%CI: 1.62-13.6). p<0.01
Parenteral exposure alcoholism OR = 12.8 (95%CI: 1.59-103) p<0.01
OR – odds ratio (confidence interval), ARV - antiretroviral




No Condom use Condom use > 50%
Age (years) 53.6 ± 7.42 41.2 ± 11.18 p = 0.03
Condom use < 50% Condom use > 50%
Age (years) 47.78 ± 9.21 41.2 ± 11.18 P = 0.04
ARV use (yes) ARV use (no)
Time since diagnosis (years) 11.06 ± 7.37 3.44 ± 3.5 p < 0.01
alcoholism (yes) alcoholism (no)
Time since diagnosis (years) 16.5 ± 8.86 9.86 + 7.04 p < 0.01
Detectable viral load undetectable viral load
Time of use of ARV 4.44 ± 5.07 4.81 ± 3.82 p < 0.01
ARV (yes) ARV (no)
CD4+ 489.76 ± 299.99 601.1 ± 419 p = 0.015
circuncision (sim) circuncision (no)
Viral load (detectables) 7569 ± 15604 130527 ± 238358 p < 0.01
Illicit drugs (yes) Illicit drugs (no)
Viral load (detectables) 42733 ± 86483 125930 ± 246920 p = 0.02
DP – standard deviation, ARV – antirretroviral.
Table 3 - Statistically significant associations between continuous variables (N = 115)
Variable Result
Age x Time of use of ARV β = positive, R² = 0.082 p<0.01
Time since diagnosis x Time of use of ARV β = positive, R² = 0.231 p<0.01
Time of use of ARV x CD4+ β = positive, R² = 0.073 p<0.01
CD4+ x detectable viral load β = negative, R² = 0.2 p<0.01
ARV – antirretroviral, β – angular coefficient, R² - determination coefficient.
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variables associated with the presence of asymptomatic 
urethritis was not extensively explored in the cited studies. 
The relevant associations found were a history of venereal 
lymphogranuloma in the last 12 months and positive 
serology for herpes simplex virus type 213-15. The absence 
of N. gonorrhoeae causing asymptomatic urethritis in our 
samples could be explained by local epidemiologic factors 
and antibiotic use in the last year in 38.2% of all patients.
During the early epidemic period, it was recognized 
that the coexistence of STI increases the risk of HIV 
transmission and that control of these diseases is a measure 
not to be neglected, especially in populations with a high 
prevalence of HIV infection, low prevalence of circumcised 
individuals and among those who engage in sexual practices 
that brings about a higher risk of transmission16. The 
presence of asymptomatic STI is a challenge for clinical 
practice11. We recommend that, in outpatient practice, 
the habit of inquiring on previous sexual behavior to 
obtain more information about risks and associations with 
asymptomatic STI, a routine physical examination and 
complementary tests to detect STI pathogens should be 
performed to discard these conditions. The development 
of rapid tests for this purpose should also be encouraged.
Regarding the associations found, we can say that the 
association between age and ART use time was influenced 
by temporal probability; thus, the patients aged while using 
ART. Patients who have used ART for a longer time also 
have a longer time since the diagnosis of the HIV infection 
and higher CD4+ T-lymphocyte counts with an undetectable 
viral load. Individuals with detectable viral loads have a 
lower CD4+ T-lymphocyte count. Subjects who did not use 
ART, corresponding to 8.8% of the sample, had a higher 
CD4+ T-lymphocyte count, which would explain the non-
initiation of ART by individualized medical decisions. 
Patients using prophylaxis are associated with detectable 
viral loads, which may reflect clinical and antiviral failure 
or even poor adherence to treatment. All these claims have 
biological plausibility and are expected in individuals being 
treated for HIV infections.
The mean age of the patients is higher in categories 
where condom use is less frequent. These data reflect a 
resistance of the older age groups regarding the use of 
condoms, which may be influenced by cultural sexual 
behaviors of their youth. 
Uncircumcised men are associated with the highest mean 
plasma HIV viral load among patients with detectable HIV 
viral loads compared to circumcised ones. The presence of 
inflammatory processes in the foreskin (balanitis) could 
negatively influence viral load control and increase viral 
replication in these individuals. This hypothesis needs to 
be confirmed in subsequent studies.
Patients positive for C. trachomatis urethritis have a 
lower mean age compared to non-urethritis individuals, 
although the lower mean age was associated with the more 
frequent use of condoms in the sample studied.
About the limitations, the study is limited to just one 
Hospital that is reference in treating patients living with 
HIV so that the population studied cannot be considered 
representative of all males living with HIV in Brazil. 
As a cross-sectional study, exposure and outcomes were 
simultaneously assessed and, in general, there is no evidence 
of a temporal relationship. It would be interesting to study 
asymptomatic urethritis among people living with HIV in 
the group younger than 18 years old. This group has an own 
pattern of socio demographic and behavioral characteristics 
and can have different prevalence of asymptomatic urethritis 
compared to our study. The refusal rate to participate in 
the study (13 patients – 4.1%), those who were declared 
unable to perform the exams (27 patients – 8.5%), or 
did not attend the scheduling phases of the collection or 
treatment (60 patients – 19.1%) corresponded to 31.7% of 
the initial sample (314 patients). Those unable to perform 
the exams had some kind of genitourinary problem, for 
example, urinary infection symptoms (considered not 
asymptomatic). Individuals that refused to participate or 
missed the scheduled exams (23.2%) could generate bias 
in our results, as long as this kind of situation is considered 
a standard of health neglect, raising the possibility that 
this group can have a higher prevalence of asymptomatic 
urethritis.
In conclusion, asymptomatic urethritis in male 
populations living with HIV should not be neglected and 
may possibly play a role in HIV transmission.
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